LEXICON PHARMACEUTICALS INC (LXRX)
US5288723027 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 300K -98.75% | 100K -66.67% | 1.204M 1,104.00% | 11.353M 842.94% | 13.596M 19.76% | 27.46M 101.97% | 76.417M 178.28% | 192.49M 151.89% | 471.14M 144.76% | 699.32M 48.43% | 970.8M 38.82% | |
| EBITDA YoY % growth | -86.8M 50.65% | -100.4M -15.67% | -171.196M -70.51% | -230.724M -34.77% | -194.106M 15.87% | -186.456M 3.94% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -87.1M 51.29% | -100.8M -15.73% | -171.75M -70.39% | -214.076M -24.64% | -162.367M 24.15% | -135.106M 16.79% | -151.691M -12.28% | -67.099M 55.77% | 286.07M 526.34% | 562.38M 96.59% | 903.74M 60.70% | |
| Operating Margin | -29,033.33% | -100,800.00% | -14,264.95% | -1,885.63% | -1,194.23% | -492.01% | -198.50% | -34.86% | 60.72% | 80.42% | 93.09% | |
| EPS YoY % growth | -0.61 -1.67% | -0.61 0.00% | -0.80 -31.15% | -0.70 12.15% | -0.47 32.83% | -0.43 9.61% | -0.33 21.90% | 0.12 136.73% | 0.79 541.67% | 1.54 96.10% | 1.93 25.17% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.13 36.59% | -0.13 36.25% | -0.13 25.00% | -0.13 29.17% | -0.12 3.48% | -0.16 -28.00% | -0.16 -28.00% | -0.16 -28.00% | -0.17 -41.67% |
| Revenue Q2Q % growth | 7.133M 916.10% | 3.341M 195.66% | 4.279M 159.81% | 6.584M 276.23% | 9.802M 37.42% | 18.391M 450.46% | 20.278M 373.90% | 25.765M 291.33% | 21.369M 118.01% |
| EBITDA Q2Q % growth | -56.06M -21.39% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -48.839M -4.50% | -46.114M -1.72% | -47.317M 14.52% | -46.862M 26.42% | -45.638M 6.55% | -59.035M -28.02% | -61.067M -29.06% | -57.739M -23.21% | -63.849M -39.90% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.18 14.29% | -0.17 | -0.01 | -7.28% |
| Q2 2024 Q2Q % growth | -0.17 22.73% | -0.19 | 0.02 | 11.66% |
| Q1 2024 Q2Q % growth | -0.20 -17.65% | -0.20 | 0.00 | 0.72% |
| Q4 2023 Q2Q % growth | -0.20 -25.00% | -0.22 | 0.02 | 9.75% |
| Q3 2023 Q2Q % growth | -0.21 -61.54% | -0.22 | 0.01 | 4.13% |
| Q2 2023 Q2Q % growth | -0.22 -37.50% | -0.18 | -0.04 | -23.43% |
| Q1 2023 Q2Q % growth | -0.17 -6.25% | -0.18 | 0.01 | 7.02% |
| Q4 2022 Q2Q % growth | -0.16 5.88% | -0.14 | -0.02 | -17.06% |
| Q3 2022 Q2Q % growth | -0.13 18.75% | -0.14 | 0.01 | 8.53% |
| Q2 2022 Q2Q % growth | -0.16 -23.08% | -0.16 | 0.00 | 0.30% |
| Q1 2022 Q2Q % growth | -0.16 -6.67% | -0.17 | 0.01 | 4.74% |
| Q4 2021 Q2Q % growth | -0.17 -325.00% | -0.19 | 0.02 | 8.76% |
| Q3 2021 Q2Q % growth | -0.16 -122.86% | -0.18 | 0.02 | 11.38% |
| Q2 2021 Q2Q % growth | -0.13 79.37% | -0.16 | 0.03 | 20.22% |
| Q1 2021 Q2Q % growth | -0.15 76.19% | -0.16 | 0.01 | 6.57% |
| Q4 2020 Q2Q % growth | -0.04 91.67% | -0.28 | 0.24 | 85.82% |
| Q3 2020 Q2Q % growth | 0.70 -66.82% | 0.27 | 0.43 | 160.20% |
| Q2 2020 Q2Q % growth | -0.63 -186.36% | -0.62 | -0.01 | -1.63% |
| Q1 2020 Q2Q % growth | -0.63 -200.00% | -0.71 | 0.08 | 11.08% |
| Q4 2019 Q2Q % growth | -0.48 -200.00% | -0.79 | 0.31 | 39.00% |
| Q3 2019 Q2Q % growth | 2.11 911.54% | 0.74 | 1.37 | 183.84% |
| Q2 2019 Q2Q % growth | -0.22 33.33% | -0.08 | -0.14 | -180.11% |
| Q1 2019 Q2Q % growth | -0.21 47.50% | -0.23 | 0.02 | 7.68% |
| Q4 2018 Q2Q % growth | -0.16 | -0.30 | 0.14 | 45.87% |
| Q3 2018 Q2Q % growth | -0.26 | -0.34 | 0.08 | 23.57% |
| Q2 2018 Q2Q % growth | -0.33 | -0.35 | 0.02 | 4.51% |
| Q1 2018 Q2Q % growth | -0.40 | -0.46 | 0.06 | 13.30% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 1.75M 980.25% | 2.988M | -1.238M | -41.43% |
| Q2 2024 Q2Q % growth | 1.647M 419.56% | 2.887M | -1.24M | -42.95% |
| Q1 2024 Q2Q % growth | 1.13M 4,608.33% | 1.429M | -299K | -20.92% |
| Q4 2023 Q2Q % growth | 702K | 1.267M | -565K | -44.59% |
| Q3 2023 Q2Q % growth | 162K | 2.101M | -1.939M | -92.29% |
| Q2 2023 Q2Q % growth | 317K | 68.003K | 248.997K | 366.15% |
| Q1 2023 Q2Q % growth | 24K | 33.997K | -9.997K | -29.40% |
| Q4 2022 Q2Q % growth | 51K | -51K | -100.00% | |
| Q3 2022 Q2Q % growth | 51K | -51K | -100.00% | |
| Q2 2022 Q2Q % growth | -100.00% | 51K | -51K | -100.00% |
| Q1 2022 Q2Q % growth | 51K | -51K | -100.00% | |
| Q4 2021 Q2Q % growth | -100.00% | % | ||
| Q3 2021 Q2Q % growth | -100.00% | % | ||
| Q2 2021 Q2Q % growth | 200K -97.83% | 9.18K | 190.82K | 2,078.65% |
| Q1 2021 Q2Q % growth | -100.00% | 1.71M | -1.71M | -100.00% |
| Q4 2020 Q2Q % growth | 200K -97.70% | 112.2K | 87.8K | 78.25% |
| Q3 2020 Q2Q % growth | 6.6M -97.76% | 17.21M | -10.61M | -61.65% |
| Q2 2020 Q2Q % growth | 9.2M -5.15% | 9.006M | 194K | 2.15% |
| Q1 2020 Q2Q % growth | 8M -13.04% | 7.944M | 56K | 0.70% |
| Q4 2019 Q2Q % growth | 8.7M -50.00% | 10.471M | -1.771M | -16.91% |
| Q3 2019 Q2Q % growth | 294.4M 4,105.71% | 65.535M | 228.865M | 349.23% |
| Q2 2019 Q2Q % growth | 9.7M -29.71% | 29.089M | -19.389M | -66.65% |
| Q1 2019 Q2Q % growth | 9.2M -63.78% | 13.532M | -4.332M | -32.01% |
| Q4 2018 Q2Q % growth | 17.4M | 13.593M | 3.807M | 28.01% |
| Q3 2018 Q2Q % growth | 7M | 12.813M | -5.813M | -45.37% |
| Q2 2018 Q2Q % growth | 13.8M | 16.179M | -2.379M | -14.70% |
| Q1 2018 Q2Q % growth | 25.4M | 22.651M | 2.749M | 12.14% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 3.87% | 35.98% | -0.24% | -0.49% |
| Revenue | -1.41% | -43.32% | -28.15% | -32.11% |